Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Filings indexed 1,562 across all filing types
Latest filing 2021-12-03 Director's Dealing
Country TW Taiwan
Listing TW 1760

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
110年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, independent directors, and senior management. It focuses on the disclosure of insider shareholdings and pledges, which is typical of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document length is about 2993 characters, which is consistent with a detailed insider shareholding disclosure rather than a full report or announcement. Therefore, the document is best classified as a Director's Dealing (DIRS) filing.
2021-12-03 Chinese
110年10月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tabular data showing shareholdings of insiders, including directors, managers, and their related parties. It lists share types, quantities held at different times, increases and decreases in holdings, and other related information. This type of document is characteristic of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but contains substantive data on insider shareholdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-11-12 Chinese
110年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, independent directors, general managers, and other executives. It provides specific data on share counts, pledged shares, and related percentages. The content focuses on insider shareholdings and their changes, which aligns with reporting on personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document length is under 5,000 characters and is not an announcement of a report but a direct disclosure of insider shareholdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-11-12 Chinese
110年第3季財務報告書 — 202104_1760_AI3.pdf
Annual Report Classification · 95% confidence The document is titled "個體財務報告暨會計師查核報告" which translates to "Individual Financial Report and Auditor's Report" for fiscal years 110 and 109 (Taiwanese calendar years corresponding to 2021 and 2020). It contains detailed financial statements such as balance sheets, income statements, cash flow statements, notes to financial statements, and an auditor's report by KPMG. The length is substantial (15,000 characters), and the content includes comprehensive financial data and accounting policies. This matches the characteristics of an Annual Report (10-K equivalent) rather than a standalone audit report or interim report. Therefore, the document is classified as an Annual Report (10-K). FY 2021
2021-11-11 Chinese
110年第3季財務報告書 — 202104_1760_AI1.pdf
Annual Report Classification · 100% confidence The document is a consolidated financial report including an auditor's report for the fiscal years 110 and 109 (Taiwanese calendar years corresponding to 2021 and 2020). It contains detailed financial statements such as consolidated balance sheets, income statements, cash flow statements, notes on accounting policies, and auditor's opinions. The presence of an auditor's report and comprehensive financial data indicates this is a full annual report. The document is lengthy (15,000 characters) and contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2021
2021-11-11 Chinese
110年第3季財務報告書 — 202103_1760_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "合併財務報告暨會計師核閱報告" which translates to "Consolidated Financial Report and Auditor's Review Report". It includes detailed financial statements such as consolidated balance sheets, income statements, cash flow statements, notes on accounting policies, and auditor's review report. The document covers financial data for the third quarter of the years 110 and 109 (Taiwanese calendar years, corresponding roughly to 2021 and 2020). The length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. The presence of an auditor's review report alongside the consolidated financial statements indicates this is an interim or quarterly financial report rather than a full annual report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2021
2021-11-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.